Uzbekistan Aims to Become a Regional Pharmaceutical Hub in Eurasia
Officials say Uzbekistan’s fast-growing pharmaceutical sector could become a key healthcare and manufacturing hub for Central Asia and Eurasia
Pharmaceutics
Uzbekistan Relaxes Customs Rules on Dietary Supplements and Vitamins
Supplements currently make up nearly 10% of the national pharmacy market
Uzbekistan Aims for $697 Mln in Pharmaceutical Production in 2026
The government will provide support to domestic producers
Uzbekistan Plans $1 Bn in New Pharmaceutical Projects
Authorities say these projects could enable domestic production of medicines
EBRD Backs Uzbekistan Pharma Industry With €20 Mln Loan
The funds will be used to purchase new production lines
EBRD Backs Nika Pharm With $20 Mln to Boost Local Drug Production in Uzbekistan
The funding will be used to restructure the company’s balance sheet
Uzbekistan and Poland Eye Stronger Cooperation in Pharmaceuticals
The Polish side welcomed Uzbekistan’s adoption of global standards, including the World Listed Authority (WLA) system
NHS Issues Guidance on Long-Term Use of Omeprazole
Noya Ca Pharmaceutical to Invest $14.6 Mln in Drug Production in Uzbekistan
There are plans to establish the production of psychotherapeutic drugs.
EBRD to Provide $25 Mln Loan to Pharma Company Meros Pharm
The funding will help the distributor expand its warehouse network
Uzbek Pharma Market Projected to Grow by 13% in 2024
As stated by STADA
Uzbekistan to Introduce Duties On Imported Antibiotics
Starting from April 2025
Uzbek Pharmaceutical Startups To Receive Investments From Venture Fund
Decree signed by the Head of State
Customs Benefits for Pharmaceutical Companies Extended Until 2028
The President of Uzbekistan made this announcement
Mirziyoyev Unveils UZS 20 Billion Initiative to Strengthen Pharma Sector
The funds will be provided as grants
Juris Bundulis, Chairman of the Board of Olainfarm: Compelling Investment Opportunity in Promising Market
The Latvian pharmaceutical company aims to 'revitalise' Central Asia and has specific plans for Uzbekistan.
State investments and regulatory framework
IQVIA outlines growth conditions for Uzbekistan’s pharmaceutical market
Vladislav Bessarabov: Standardisation of Rules as a Growth Factor for the Pharmaceutical Business
What challenges do foreign companies face in the Central Asian market